Navigation Links
Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
Date:12/15/2007

SAN ANTONIO, Dec. 15 /PRNewswire/ -- Interim results of the Phase II XeNA (Xeloda in NeoAdjuvant) trial suggest that the combination of oral Xeloda(R) (capecitabine) and Taxotere(R) (docetaxel), with the addition of Herceptin(R) (trastuzumab) in HER2-positive patients, may be an active and well-tolerated neoadjuvant (pre-surgical) treatment option for women with invasive breast cancer. These data were presented today at the San Antonio Breast Cancer Symposium (SABCS).

In the multi-center, open-label trial -- designed to investigate the activity of a short non-anthracycline-based preoperative treatment for early breast cancer in both HER2-negative and HER2-positive patients -- promising results were achieved after only four cycles of pre-surgical treatment as compared to the standard eight cycles. The majority of the 156 patients responded to the Xeloda-based therapy regardless of HER2 status, and both patient groups experienced a clinically significant reduction in tumor size.

"These early XeNA trial results highlight the potential of the Xeloda/Taxotere combination, with Herceptin for HER2-positive patients, to provide an effective and safe treatment option in a shorter period of time before surgery among patients with invasive breast cancer," said Dr. Debu Tripathy, lead investigator of the XeNA trial and Professor of Medicine and Director of the Komen/UT Southwestern Breast Cancer Research Program at the University of Texas Southwestern Medical Center at Dallas. "While these findings warrant additional studies, the real-world impact of the reduction in tumor size could translate into the difference between a lumpectomy instead of a more drastic mastectomy."

In the interim analysis, following four treatment cycles, the combination of Xeloda, Taxotere and Herceptin in HER2-positive patients resulted in a 73 percent clinical response rate (complete and partial response) and a 50 percent pathologic response (pathologic complete response, w
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS)
2. Promising drug combination may help those with ocular melanoma that has spread
3. Combination therapy reverses effects of portal hypertension in rats
4. Combination vaccines okay for infants, study shows
5. Antidepressants and painkillers - a dangerous combination
6. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
7. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
8. Drug combination might offer hope for patients deadly brain tumors
9. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
10. Combination targets: some drugs may work best when they work together
11. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 Now in its second ... best of the best in senior living and home ... given to communities and agencies that have received outstanding ... Of the nearly 100,000 providers currently listed on SeniorAdvisor.com, ... the SeniorAdvisor.com Best of 2015 Awards are located all ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... phenomenon is when an illness that originated in animals jumps ... -- is not uncommon and keeps researchers on their toes ... make inroads into the human population. A new report ... in this case were guinea pigs. More specifically, they were ...
(Date:12/17/2014)... participation in music classes may benefit children,s language development, ... the nonprofit Harmony Project, which provides music education and ... two years, children who actively participated in the classes ... and reading, compared to those with lower levels of ... music classes occurred in the same areas of the ...
(Date:12/17/2014)... Kathleen Doheny HealthDay Reporter ... sleep loss is rampant in America, and work commitment is ... the No. 1 sleep killer," said Dr. Mathias Basner, an ... University of Pennsylvania Perelman School of Medicine. A time-use ... found that work is the main activity exchanged for sleep. ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Veretekk.com, Inc. ... JM Ocean Avenue. JM Ocean Avenue has secured ... Veretekk online automated marketing system. JM Ocean Avenue ... 2014 merger of Ocean Avenue and JM International, with ... $2 Billion per year company. , “After nearly 2 ...
Breaking Medicine News(10 mins):Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Music Classes Boost Language Skills, Study Says 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4
... Nov. 19 Tris Pharma announces,the appointment of ... Vice,President, Business Development. Tim will spearhead the company,s ... opportunities to help,companies enhance their products, life cycle ... him more than 25 years of industry experience, ...
... 19 People grow a lot in 13,years, ... the leader in,at-home diagnostic sleep testing and sleep ... rapid growth by moving into new corporate,offices. ... Growing Private,Companies in America, SleepQuest has moved its ...
... finds men with more than 3 kids are more likely ... young, trim farmer with four or more children: According to a ... reach 100 years of age. , The research, based largely on ... excess weight in youth, farming and fathering a large number of ...
... Researchers released initial data today at the 60th Annual ... (GSA) that showed that doing the right kind of ... of older adults. , Dr. Elizabeth Zelinski of the ... from the IMPACT study (Improvement in Memory with Plasticity-based ...
... 500,000 DR Images Reviewed as World,s Leading Thoroughbred ... House Converts to Digital Radiography Review, SANTA CLARA, ... auction facility, opened its doors to the,annual September Yearling ... the review of digital medical images. Beginning with 12,review ...
... Scientific,Corporation (NYSE: BSX ) today announced that ... associated with a series of product communications,issued by ... acquired,Guidant last year. This agreement amends a prior ... additional unanticipated claims. The amended agreement was ...
Cached Medicine News:Health News:Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development 2Health News:SleepQuest Continues Growth, Moves Headquarters 2Health News:Farming, Fatherhood Hallmarks of Men Who Live to 100 2Health News:Farming, Fatherhood Hallmarks of Men Who Live to 100 3Health News:Farming, Fatherhood Hallmarks of Men Who Live to 100 4Health News:New research on aging and cognitive training presented at GSA's Annual Meeting 2Health News:Keeneland Scales Eklin Digital Repository(TM) to 32 Medical Image Review Workstations 2Health News:Keeneland Scales Eklin Digital Repository(TM) to 32 Medical Image Review Workstations 3Health News:Boston Scientific Announces Amended Agreement to Settle Product Lawsuits 2Health News:Boston Scientific Announces Amended Agreement to Settle Product Lawsuits 3
(Date:12/15/2014)... 2014  Colorado and Washington State ... of cannabis. Oregon , Alaska ... prohibition during the November 2014 elections. Photo ... The benefits of legalizing cannabis are ... like the increased tax revenue for state and local governments, ...
(Date:12/15/2014)... 15, 2014  Stephen Squires, CEO and founder of ... Corp (OTCQB:QTMM), will be speaking at the launch ... on December 16th, 2014. The RCQM launch continues Rice ... attracting top faculty and students and by inviting the ... "We have a long association with ...
(Date:12/15/2014)... and BOSTON , December 15, ... GPCR structure-guided drug discovery and development company, is pleased ... the United States relating to ... patents in the US significantly strengthens the global patent ... pharmaceutical markets. The suite of patents recently ...
Breaking Medicine Technology:CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2
... 12 Eisai Inc. (Headquarters: Woodcliff Lake, New Jersey , Chairman and CEO: Hajime Shimizu ... ,s Brain Science Institute (Headquarters: Baltimore, Maryland , Director: John Griffin , M.D., "BSI") related to ... ... , ...
... has accepted the proposed proprietary name "Exelbine™" for the Company,s product candidate ANX-530 (vinorelbine injectable emulsion). , ... , , ... ... ...
Cached Medicine Technology:Eisai Enters Licensing Agreement with Johns Hopkins Brain Science Institute 2Eisai Enters Licensing Agreement with Johns Hopkins Brain Science Institute 3ADVENTRX Receives Brand Name Acceptance for ANX-530 2ADVENTRX Receives Brand Name Acceptance for ANX-530 3ADVENTRX Receives Brand Name Acceptance for ANX-530 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: